添加微信 添加微信
首页: 全球医药政策

美国-WuXi LABORATORY

时间:2021-10-21 21:14:26 来源:康安医药咨询 作者:康安医药咨询

WuXi AppTec’s Laboratory Testing Division is a comprehensive and integrated testing platform for drug and medical device development. Fully integrated within WuXi AppTec, a world-class CRO with operations in China and the US, the Laboratory Testing Division provides in vivo and in vitro assays from early screening through clinical sample analysis, and medical device testing from development through product lifecycle management. We operate with full transparency, providing the high-quality data you need to advance your project while meeting international standards for regulatory compliance and maintaining industry-leading turnaround times. The Laboratory Testing Division consists of three integrated testing platforms—WuXi AppTec IND (WIND) for Preclinical Drug Development; Clinical Drug Development; and Medical Device Testing. Each platform is supported by the complementary capabilities of our four service units, which include Analytical, Bioanalytical, Toxicology and DMPK services. Testing services are offered as a comprehensive package in support of global IND/NDA filings, or on a standalone basis, with customized study designs available to meet the varying needs of our diverse client base.

Phone: 1, (609), 799, 2295 E-mail: info_ltd@wuxiapptec.com
Web: https://labtesting.wuxiapptec.com/
Add:R&D Facility for DMPK & Bioanalytical Services 107 Morgan Lane Plainsboro, NJ 08536 USA

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:kanganzixun

当前栏目

频道栏目

最新文章

热门文章